Maternal folate status and neural tube defects in Ireland: The need for a national food fortification program

Irish Medical Journal

Volumn 100, Issue 5, 2007, Pages

  Walsh, T ^b   McMillan, H ^b   Harrison, R F ^b   Geary, Michael P P ^a   McMahon, C Geraldine ^b   O'Broin, Sean ^b   Donnelly, Jennifer ^b   Cooley, S ^b  

^a ROTUNDA HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADULT; ANENCEPHALUS; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ERYTHROCYTE; FEMALE; FOLIC ACID BLOOD LEVEL; FOOD INTAKE; GESTATIONAL AGE; HEALTH PROGRAM; HUMAN; IRELAND; LIFESTYLE; MAJOR CLINICAL STUDY; MATERNAL WELFARE; NEURAL TUBE DEFECT; PREGNANCY; PRENATAL PERIOD; PREVALENCE; PRIMIGRAVIDA; RISK ASSESSMENT; SOCIOECONOMICS; SPINA BIFIDA; BLOOD; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; FOLIC ACID DEFICIENCY; INFANT; NEWBORN; NUTRITIONAL STATUS; PROGRAM DEVELOPMENT; RISK FACTOR;

CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOOD, FORTIFIED; HUMANS; INFANT; INFANT, NEWBORN; IRELAND; MATERNAL WELFARE; NEURAL TUBE DEFECTS; NUTRITIONAL STATUS; PREGNANCY; PROGRAM DEVELOPMENT; RISK FACTORS;

EID: 34547577502     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Prevention of Neural Tube Defects: Results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 20-7-1991;338(8760):131-7.
2. Kirke, P. N., Daly, L. E., and Elwood, J. H. A Randomised Trial of Low Dose Folic Acid to Prevent Neural Tube Defects. The Irish Vitamin Study Group. Arch.Dis.Child 1992;67(12):1442-6.
3. Berry, R. J., Li, Z., Erickson, J. D., et al. Prevention of Neural-Tube Defects With Folic Acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N.Engl.J.Med. 11-11-1999;341(20):1485-90.
4. Scott, J. M., Kirke, P. N., and Weir, D. G. Folic Acid in the Prevention of Neural Tube Defects. Ir.J Med.Sci. 1992;161(10):579-81.
5. Recommendations for the Use of Folic Acid to Reduce the Number of Cases of Spina Bifida and Other Neural Tube Defects. MMWR Recomm.Rep 11-9-1992;41(RR-14):1-7.
6. Food and drug administration, USA, and (FDA). Food Standards:Amendment of Standards of Identity for Enriched Grain Products to Require Addition of Folic Acid:Final Rule(21 CFR Parts 136,137 and 139). Federal Register 1996;61:8787-97.
7. Williams, L. J., Mai, C. T., Edmonds, et al. Prevalence of Spina Bifida and Anencephaly During the Transition to Mandatory Folic Acid Fortification in the United States. Teratology 2002;66(1):33-9.
8. Kirke, P. N., Molloy, A. M., Daly, L. E., Burke, H., Weir, D. G., and Scott, J. M. Maternal Plasma Folate and Vitamin B12 Are Independent Risk Factors for Neural Tube Defects. Q.J Med. 1993;86(11):703-8.
9. Daly, L. E., Kirke, P. N., Molloy, A., Weir, D. G., and Scott, J. M. Folate Levels and Neural Tube Defects. Implications for Prevention. JAMA 6-12-1995;274(21):1698-702.
10. O'Broin, S. and Kelleher, B. Microbiological Assay on Microtitre Plates of Folate in Serum and Red Cells. J.Clin. Pathol. 1992;45(4):344-7.
11. Wickham, C., O'Broin, S., and Kevany, J. Seasonal Variation in Folate Nutritional Status. Ir.J Med.Sci. 1983;152(8):295-9.
12. Harrington, K. E., McGowan, M. J., Kiely, M., et al. Macronutrient Intakes and Food Sources in Irish Adults: Findings of the North/South Ireland Food Consumption Survey. Public Health Nutr. 2001;4(5A):1051-60.
13. Philpott, N., Kelleher, B. P., Smith, O. P., and O'Broin, S. D. High Serum Folates and the Simplification of Red Cell Folate Analysis. Clin.Lab Haematol. 2001;23(1):15-20.
14. Gunter, E. W., Bowman, B. A., Caudill, S. P., Twite, D. B., Adams, M. J., and Sampson, E. J. Results of an International Round Robin for Serum and Whole-Blood Folate. Clin.Chem 1996;42(10):1689-94.
15. Van den, Berg H., Finglas, P. M., and Bates, C. FLAIR Intercomparisons on Serum and Red Cell Folate. Int.J Vitam. Nutr.Res. 1994;64(4):288-93.
16. Pfeiffer, C. M., Fazili, Z., McCoy, L., Zhang, M., and Gunter, E. W. Determination of Folate Vitamers in Human Serum by Stable-Isotope-Dilution Tandem Mass Spectrometry and Comparison With Radioassay and Microbiologic Assay. Clin. Chem 2004;50(2):423-32
17. Ward, M., Hutton, J., Mc, Donnell R., et al. Folic Acid Supplements to Prevent Neural Tube Defects: Trends in East of Ireland 1996-2002. Ir.Med.J. 2004;97(9):274-6
18. Byrne, J., Byrne, C., and Collins, D. Trends in Periconceptional Folic Acid Use by Relatives in Irish Families With Neural Tube Defects. Ir.Med.J. 2001;94(10):302-5.
19. Oakley, G. P., Jr. Oral Synthetic Folic Acid and Vitamin B12 Supplements Work - If One Consumes Them. Nutr.Rev. 2004;62(6 Pt 2):S22-S26.
20. Mansoor, M. A., Kristensen, O., Hervig, T., et al. A. Low Concentrations of Folate in Serum and Erythrocytes of Smokers: Methionine Loading Decreases Folate Concentrations in Serum of Smokers and Nonsmokers. Clin. Chem 1997;43(11):2192-4.
21. Van Wersch, J. W., Janssens, Y., and Zandvoort, J. A. Folic Acid, Vitamin B(12), and Homocysteine in Smoking and Non-Smoking Pregnant Women. Eur.J Obstet.Gynecol.Reprod.Biol. 10-6-2002;103(1):18-21.
22. Greer, I. A. Thrombosis in Pregnancy: Maternal and Fetal Issues. Lancet 10-4-1999;353(9160):1258-65.
23. Department of Health London and COMA. Folic Acid the Prevention of Disease. Report of the Committee on Medical Aspects of Food and Nutrition Policy. London: The Stationery Office 2000.
24. Wright, A. J., Finglas, P. M., and Southon, S. Proposed Mandatory Fortification of the UK Diet With Folic Acid: Have Potential Risks Been Underestimated? Trends in Food Science & Technology, 2000; 12(9):313-21.
25. Hernandez-Diaz, S., Werler, M. M., Louik, C., and Mitchell, A. A. Risk of Gestational Hypertension in Relation to Folic Acid Supplementation During Pregnancy. Am.J Epidemiol. 1-11-2002;156(9):806-12.
26. Graham, I. M., Daly, L. E., Refsum, H. et al. Plasma Homocysteine As a Risk Factor for Vascular Disease. The European Concerted Action Project. JAMA 11-6- 1997;277(22):1775-81.
27. Boushey, C. J., Beresford, S. A., Omenn, G. S., and Motulsky, A. G. A Quantitative Assessment of Plasma Homocysteine As a Risk Factor for Vascular Disease. Probable Benefits of Increasing Folic Acid Intakes. JAMA 4-101995;274(13):1049-57.